Mein Warenkorb

Glypican 1

Glypican 1 Molekülinformation

Englischer NameGlypican-1Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel1Target-AliasEpididymis Secretory Sperm Binding Protein,GPC1,Glypican 1,Glypican Proteoglycan 1,Glypican-1,Glypican,GPC-1
Höchste Forschungs- und EntwicklungsphasePhase 1 Clinical
Englischer NameGlypican-1
Target-AliasEpididymis Secretory Sperm Binding Protein,GPC1,Glypican 1,Glypican Proteoglycan 1,Glypican-1,Glypican,GPC-1
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel1
Höchste Forschungs- und EntwicklungsphasePhase 1 Clinical

Glypican 1 Produktliste

  • Attribut

    Protein (6)

  • Produktbibliothek

    Online (6)

  • Spezies

    Human (4)Mouse (1)Cynomolgus (1)

  • Etikett

    His Tag (4)Fc Tag (1)His Tag & Avi Tag (1)

  • Marker

    Unconjugated (5)Biotin-labeled (1)

Glypican 1 Molekülhintergrund

Glypican 1 has been shown to interact with SLIT2. This protein is involved in the misfolding of normal prion proteins in the cell membrane to the infectious prion form. Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation.

Glypican 1 Molekülalias

Glypican 1,GPC1

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
MiltuximabMIL-38/Gallium67Phase 1 ClinicalGlytherixPancreatic Neoplasms; Prostatic Neoplasms; Urinary Bladder Neoplasms
Details
  • Molekülinformation
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns